
|Articles|November 1, 2004
Barbotage cytology gives way to biopsy
Ann Arbor, MI-Urologists should use biopsy, not barbotage cytology, to assess tumors and select treatment for upper-tract urothelial carcinomas, advise researchers at the University of Michigan Urology Center in Ann Arbor.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
4
Optimizing care for men with overactive bladder, with Keith Xavier, MD
5






